Telemonitoring of Type 2 Diabetes Mellitus in Italy.

Source: Dario, C., et al. 2017 - Pubmed ID: 27379995

Setting: Italy,

Study design:

RCT

Follow up: 12 months.

Patient group:

ample size:

Total: 299(243)

IG: 208 (166)

CG: 91 (77)

Inclusion criteria:

– Diabetes type2

– HbA1c > 53mmol/mol (7.0%)

Type of technology:

Home monitoring

– Glucometer

– Home care portal (Gateway for data transmission.)

Intervention:

Intervention: Patients monitored and transmitted data to an eHealth Center. Clinicians could access the Home

Care portal any time and were informed when anomalies were detected, to take appropriate action.

Duration: NA

Add on: NA

 

Control group: Usual care

Clinical effect/ Patient safety:

Clinical effect:

– HbA1c →

– Physical Component Summary →

– Mental Component Summary ↓ (worse)

Patient safety:

NA

Patient experiences/ Staff experiences:

Patient experiences:
NA
Staff experiences:
NA

Costs and organization:

Investment:

Home monitoring equipment

– Blood glucose

Running:

Staff resources

– staff for monitoring clinical data

Organization:

NA

Health care utilization:

– Outpatient visits to diabetologists ↓

– Planned hospitalization ↓

– Emergency department visits →

– Bed days for hospitalized patients →

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)